title: Radioiodine ablation for differentiated thyroid cancer-none, one dose or two?
abstract: Patients with good prognosis differentiated thyroid cancer are at risk from over-treatment with radioiodine thyroid remnant ablation. Some with unfavourable localised disease might benefit from an elective second dose.
authors.affiliation: Royal United Hospital, Bath, UK. garethrees@doctors.org.uk
authors.forename: G J G
authors.initials: GJ
authors.lastname: Rees
mesh_terms: D002454:Cell Differentiation / Q000528:radiation effects*; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage*; D010166:Palliative Care; D011379:Prognosis; D011836:Radiation Tolerance / Q000528:radiation effects*; D011879:Radiotherapy Dosage; D013964:Thyroid Neoplasms / Q000532:radiotherapy*; D016896:Treatment Outcome
chemical_list: D007457:Iodine Radioisotopes